Shenyang Xingqi Pharmaceutical Co.,Ltd

Shenzhen Stock Exchange 300573.SZ

Shenyang Xingqi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2023: USD 285.06 M

Shenyang Xingqi Pharmaceutical Co.,Ltd Total Assets is USD 285.06 M for the year ending December 31, 2023, a 10.33% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Shenyang Xingqi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2022 was USD 258.37 M, a -2.68% change year over year.
Shenyang Xingqi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2021 was USD 265.48 M, a 79.44% change year over year.
Shenyang Xingqi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2020 was USD 147.95 M, a 20.87% change year over year.
Shenyang Xingqi Pharmaceutical Co.,Ltd Total Assets for the year ending December 31, 2019 was USD 122.40 M, a 18.82% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shenzhen Stock Exchange: 300573.SZ

Shenyang Xingqi Pharmaceutical Co.,Ltd

CEO	Ms. E. Gao
IPO Date	Dec. 9, 2016
Location	China
Headquarters	No. 68, Lishui Street
Employees	1,995
Sector	Health Care
Industries Pharmaceuticals Cosmetics Eyewear

Description

Shenyang Xingqi Pharmaceutical Co., Ltd engages in the research and development, production, and sale of ophthalmic products in China. It offers corneal, anti-bacteria, artificial tears, anti-inflammation, surgical perfusate, mydriactics, anti-fatigue, and pre dry and over dry eye treatment products. The company is based in Shenyang, China.

Key trends

Past 5 years